Statistics for Weighing Benefits and Harms in a Proposed Genetic Substudy of a Randomized Cancer Prevention Trial

DOI10.1111/J.1467-9876.2005.00522.XMaRDI QIDQ5757807zbMATH OpenOpenAlexFDO

Authors Stuart G. Baker, Barnett S. Kramer

Publication date 7 September 2007

Published in Journal of the Royal Statistical Society Series C: Applied Statistics (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1111/j.1467-9876.2005.00522.x

Mathematics Subject Classification ID

Estimation in survival analysis and censored data (62N02) Applications of statistics to biology and medical sciences; meta analysis (62P10)

Recommendations

• Inference of Tamoxifen's Effects on Prevention of Breast Cancer From a Randomized Controlled Trial
• Augmented case-only designs for randomized clinical trials with failure time endpoints
• scientific article; zbMATH DE number 756198
• Ethical issues in oncology biostatistics
• scientific article; zbMATH DE number 3854264

Cites work

• Genetic Susceptibility to Prostate, Breast, and Colorectal Cancer among Nordic Twins

Cited in

(4)

• Design and inference for cancer biomarker study with an outcome and auxiliary-dependent subsampling
• Statistical adjustment for a measure of healthy lifestyle doesn’t yield the truth about hormone therapy
• An approach to evaluating and comparing biomarkers for patient treatment selection
• Biomarker evaluation in randomized trials: addressing different research questions

Describes a project that uses

Uses Software

• Mathematica

This page was built for publication: Statistics for Weighing Benefits and Harms in a Proposed Genetic Substudy of a Randomized Cancer Prevention Trial

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5757807)